Scientists investigate cancer radiotherapy to make improvements

A University of Rochester Medical Center study shows that when tumors are treated with radiotherapy, the benefits can be hijacked by the treatment's counteraction to also trigger inflammation and dampen the body's immune response.

Published by the journal Oncotarget, the study suggests that radiotherapy (also known as ) could be more effective if it was combined with a drug that would block a specific cell that is responsible for dulling the immune system. In mice, the research team experimented by delivering an immunotherapy two days prior to radiotherapy and saw significant benefits for many different types of .

Led by Scott A. Gerber, Ph.D., assistant professor in the Department of Surgery, and graduate student Kelli A. Connolly, the research fills an important gap in knowledge. Scientists already know that radiotherapy stimulates anti-tumor and helps to control cancer's growth. What is less understood is why radiotherapy cannot cure cancer.

The answer may lie with how the immune system responds to radiotherapy when a tumor is present. The URMC and Wilmot Cancer Institute scientists discovered that radiation increases the circulation of certain harmful inflammatory cells and changes the way the immune system rallies against cancer. In many patients, the circulating level of these cells (called monocytes) is already high prior to cancer treatment and sometimes indicates a poor prognosis.

Gerber believes that the abundance of these cells, which can be measured in a simple blood test, could identify patients who might benefit most from blocking them, allowing the to fight the disease in combination with radiotherapy. Because these express a unique protein on their surface, they are an easy target for medications, the study said.

"Our observations of what happens during when cells are recruited to the tumor site and surrounding tissue has intriguing implications for how to improve treatment," said Gerber, who also has an appointment in the URMC Department of Microbiology and Immunology.


Explore further

Researchers discover how immune cells resist radiation treatment

More information: Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes. DOI: 10.18632/oncotarget.13287
Journal information: Oncotarget

Citation: Scientists investigate cancer radiotherapy to make improvements (2016, December 8) retrieved 14 October 2019 from https://medicalxpress.com/news/2016-12-scientists-cancer-radiotherapy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more